International Stem Cell (ISCO) Net Equity Issued and Repurchased (2010 - 2014)
International Stem Cell (ISCO) posted quarterly Net Equity Issued and Repurchased of $3000.0 for Q4 2014, down 98.8% year-over-year from $249000.0 in Q4 2013, and down 99.38% quarter-over-quarter from $484000.0 in Q2 2014.
International Stem Cell (ISCO) Net Equity Issued and Repurchased (2010 - 2014) Analysis & Trends
International Stem Cell (ISCO) has reported Net Equity Issued and Repurchased for 5 consecutive years, with $3000.0 the latest figure, recorded in Q4 2014.
- In Q4 2014, Net Equity Issued and Repurchased fell 98.8% year-over-year to $3000.0; the TTM figure through Dec 2018 stood at $487000.0 (changed N/A YoY), while the FY2018 annual figure was $500000.0, changed 0.0% from the prior year.
- Net Equity Issued and Repurchased eased to $3000.0 in Q4 2014 per ISCO's latest filing, from $484000.0 in the prior quarter.
- Across five years, Net Equity Issued and Repurchased topped out at $3.3 million in Q1 2013 and bottomed at -$4000.0 in Q4 2012.
- Historically, Net Equity Issued and Repurchased has averaged $851817.9 across 5 years, with a median of $530000.0 in 2011.
- Annual changes were most pronounced in 2012 — Net Equity Issued and Repurchased slumped 101.32% — and 2013, when it soared 6325.0%.
- International Stem Cell's Net Equity Issued and Repurchased stood at $1.4 million in 2010, then tumbled by 77.56% to $304000.0 in 2011, then plunged by 101.32% to -$4000.0 in 2012, then jumped by 6325.0% to $249000.0 in 2013, then tumbled by 98.8% to $3000.0 in 2014.
- Business Quant data shows ISCO's Net Equity Issued and Repurchased at $3000.0 in Q4 2014, $484000.0 in Q2 2014, and $1.1 million in Q1 2014.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 49.20 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | International Stem Cell | 3.76 Mn | 2.67 Mn | 1.46 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2014 | 3,000.00 |
| Dec 31, 2014 | 3,000.00 |
| Jun 30, 2014 | 484,000.00 |
| Jun 30, 2014 | 484,000.00 |
| Mar 31, 2014 | 1.10 Mn |
| Mar 31, 2014 | 1.10 Mn |
| Dec 31, 2013 | 249,000.00 |
| Dec 31, 2013 | 249,000.00 |
| Mar 31, 2013 | 3.29 Mn |
| Mar 31, 2013 | 3.29 Mn |
| Dec 31, 2012 | -4,000.00 |
| Dec 31, 2012 | -4,000.00 |
| Sep 30, 2012 | -1,000.00 |
| Sep 30, 2012 | -1,000.00 |
| Jun 30, 2012 | 5,000.00 |
| Jun 30, 2012 | 5,000.00 |
| Mar 31, 2012 | 2.08 Mn |
| Mar 31, 2012 | 2.08 Mn |
| Dec 31, 2011 | 304,000.00 |
| Dec 31, 2011 | 304,000.00 |